Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
BMC Cancer
; 23(1): 32, 2023 Jan 09.
Article
in En
| MEDLINE
| ID: mdl-36624467
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Food Hypersensitivity
/
Anaphylaxis
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido